Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Low-carb, high-fat diet: Friend or foe?
Low-carb, high-fat diet: Friend or foe?
24 Mar 2023
Add-on evolocumab improves plaque characteristics in statin-treated CAD patients
Add-on evolocumab improves plaque characteristics in statin-treated CAD patients
15 Mar 2023 bởiAudrey Abella

In individuals with stable coronary artery disease (CAD), intensifying their lipid-lowering regimen with evolocumab, a PCSK9* inhibitor, led to improvements in coronary plaque characteristics on intravascular imaging, findings from the YELLOW III trial have shown.

Add-on evolocumab improves plaque characteristics in statin-treated CAD patients
15 Mar 2023